首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nano today

缩写:NANO TODAY

ISSN:1748-0132

e-ISSN:1878-044X

IF/分区:10.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引151
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Peng Yang,Athena Yue-Tung Lee,Jingjing Xue et al. Peng Yang et al.
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) genome editing system has revolutionized the field of genome editing for therapeutic applications for genetic diseases and canc...
Masoud Negahdary,William Skinner,Samuel Mabbott et al. Masoud Negahdary et al.
Despite major advances, the management of cancer remains one of the greatest unresolved challenges in medicine and a leading cause of death worldwide. Thus, improved, early, and minimally invasive diagnostics are urgently demanded. In recen...
Evin Gultepe,Raghnya Valluru,Nik Bear Brown et al. Evin Gultepe et al.
Nanotechnology has transformed healthcare, leading to the clinical adoption of numerous nanomedical products. To evaluate their clinical translation, we analyzed all trials registered on ClinicalTrials.gov using a novel nanomedicine lexicon...
Hsuan-Chen Liu,Nicola Di Trani,Marzia Conte et al. Hsuan-Chen Liu et al.
Intratumoral immunotherapy holds promise for improving cancer treatment efficacy. However, rapid clearance from the tumor upon bolus volume injections limits efficacy and impedes assessment of dose-dependent effects on the tumor immune micr...
Yushuang Wei,Xiangyang Li,Yao Gong et al. Yushuang Wei et al.
Nanomaterials often need to interact with proteins on the plasma membrane to get cross and access their intracellular targets. Therefore, to fully understand the cell entry mechanism, it is of vital importance to gain a comprehensive insigh...
Wathsala Liyanage,Gokul Kannan,Sujatha Kannan et al. Wathsala Liyanage et al.
CRISPR-Cas9, a flexible and efficient genome editing technology, is currently limited by the challenge of delivering the large ribonucleoprotein complex intracellularly and into the nucleus. Existing delivery techniques/vectors are limited ...
Raghu Ganugula,Kabirat T Babalola,Ingrid M Heyns et al. Raghu Ganugula et al.
One-third of systemic lupus erythematosus (SLE) patients experience various degrees of ocular manifestations, with immunosuppressants recommended as a treatment option. Targeted immune suppression via oral administration is challenging due ...
Md Musavvir Mahmud,Nikhil Pandey,Jeffrey A Winkles et al. Md Musavvir Mahmud et al.
Nanotherapeutics have gained significant attention for the treatment of numerous cancers, primarily because they can accumulate in and/or selectively target tumors leading to improved pharmacodynamics of encapsulated drugs. The flexibility ...
Lijia Luo,Xiang Wang,Yu-Pei Liao et al. Lijia Luo et al.
The prevailing desmoplastic stroma and immunosuppressive microenvironment within pancreatic ductal adenocarcinoma (PDAC) pose substantial challenges to therapeutic intervention. Despite the potential of protein tyrosine kinase (PTK) inhibit...
Poornachander R Guda,Anu Sharma,Adam J Anthony et al. Poornachander R Guda et al.
Exosomes, a class of extracellular vesicles of endocytic origin, play a critical role in paracrine signaling for successful cell-cell crosstalk in vivo. However, limitations in our current understanding of these circulating nanoparticles hi...